» Articles » PMID: 18606106

Stroke Prevention in Women: Challenges and Opportunities

Overview
Publisher Springer
Date 2008 Jul 9
PMID 18606106
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Women have a 20% lifetime risk of stroke. In addition, the majority of stroke-related deaths occur in women. Reducing the burden of stroke in women through prevention would positively affect public health. Unfortunately, most of the data used to develop specific evidence-based guidelines for stroke prevention in women were derived from coronary heart disease studies. Stroke was a secondary and less common outcome, if it was included at all. In addition, women have traditionally been underrepresented in stroke prevention trial cohorts. Stroke prevention in women offers many challenges, not only related to data extrapolated from clinical trials primarily composed of men, but also because physicians may underestimate cardiovascular risk in women, and therefore prevention strategies may not be appropriately undertaken. The opportunities to improve stroke prevention in women include increasing patient and physician awareness of risk and optimizing management of key modifiable risk factors (eg, hypertension, hyperlipidemia, physical inactivity, obesity, and diabetes).

Citing Articles

Early identification and treatment of women's cardiovascular risk factors prevents cardiovascular disease, saves lives, and protects future generations: Policy recommendations and take action plan utilizing policy levers.

Ivey S, Hanley H, Taylor C, Stock E, Vora N, Woo J Clin Cardiol. 2022; 45(11):1100-1106.

PMID: 36128629 PMC: 9707563. DOI: 10.1002/clc.23921.


Barriers to exercise in younger and older non-exercising adult women: a cross sectional study in London, United Kingdom.

El Ansari W, Lovell G Int J Environ Res Public Health. 2009; 6(4):1443-55.

PMID: 19440527 PMC: 2681199. DOI: 10.3390/ijerph6041443.

References
1.
Berger J, Roncaglioni M, Avanzini F, Pangrazzi I, Tognoni G, Brown D . Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA. 2006; 295(3):306-13. DOI: 10.1001/jama.295.3.306. View

2.
Goldstein L, Amarenco P, Lamonte M, Gilbert S, Messig M, Callahan A . Relative effects of statin therapy on stroke and cardiovascular events in men and women: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study. Stroke. 2008; 39(9):2444-8. DOI: 10.1161/STROKEAHA.107.513747. View

3.
Mosca L, Merz N, Blumenthal R, Cziraky M, Fabunmi R, Sarawate C . Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting. Circulation. 2005; 111(4):488-93. DOI: 10.1161/01.CIR.0000153859.66086.85. View

4.
Lloyd-Jones D, Leip E, Larson M, DAgostino R, Beiser A, Wilson P . Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006; 113(6):791-8. DOI: 10.1161/CIRCULATIONAHA.105.548206. View

5.
Wing L, Reid C, Ryan P, Beilin L, Brown M, Jennings G . A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med. 2003; 348(7):583-92. DOI: 10.1056/NEJMoa021716. View